Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Root, Inc. (ROOT)

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Root, Inc. (ROOT)

LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming May 18, 2021 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Root, Inc. (“Root” or the “Company”) (NASDAQ: ROOT): (a) securities between October 28, 2020 and March 8, 2021, inclusive (the “Class Period”); and/or (b) Root Class A common stock pursuant and/or traceable to the Offering Documents issued in connection with the Company’s initial public offering on or about October 28, 2020 (the “IPO” or “Offering”).

If you suffered a loss on your Root investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, you can submit your contact information at https://www.glancylaw.com/cases/root-inc/. You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.

On December 1, 2020, post-market, Root announced its third quarter 2020 financial results, reporting revenues of $50.5 million (or down 36.6% year-over-year) and earnings per share (“EPS”) of -$2.20 per share (missing consensus estimates by $1.79 per share).

On this news, the Company’s stock fell $2.30, or over 13%, to close at $14.70 per share on December 2, 2020.

Then, on February 25, 2021, post-market, Root announced its fourth quarter and full year 2020 financial results, reporting EPS of -$0.72, missing consensus estimates by $0.07 per share.

On this news, the Company’s stock fell $2.93, or nearly 18%, to close at $13.49 per share on February 26, 2021.

Then, on March 9, 2021, BofA Securities analyst Joshua Shanker initiated coverage of Root with an “Underperform” rating on the premise that the Company is unlikely to be cash flow positive until 2027, finding that Root “will require not insignificant cash infusions from the capital markets to bridge its cash flow needs.” The report stated that already established market players would continue to impede the Company’s profitability with superior telematics data and their dominant market positions.

On this news, stock price fell $0.18 per share, or 1.46%, to close at $12.17 per share on March 9, 2021, representing a 55% decline from the IPO price.

The complaint filed alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, the Offering Documents and Defendants failed to disclose to investors that: (1) Root would foreseeably fail to generate positive cash flow for at least several years following the IPO; (2) accordingly, the Company would foreseeably require significant cash infusions to meet its cash flow needs; (3) notwithstanding the Defendants’ touting of Root’s purportedly unique, data-driven advantages, several of the Company’s established industry peers in fact possessed significant competitive advantages over Root with respect to, inter alia, telematics data and data engagement; and (4) as a result, the Offering Documents and Defendants’ public statements throughout the Class Period were materially false and/or misleading and failed to state information required to be stated therein.

Follow us for updates on LinkedIn, Twitter, or Facebook.

If you purchased or otherwise acquired Root securities during the Class Period and/or Class A common stock pursuant to the IPO, you may move the Court no later than May 18, 2021 to request appointment as lead plaintiff in this putative class action lawsuit. To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to the pending class action lawsuit, please contact Charles Linehan, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles, California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to [email protected], or visit our website at www.glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Glancy Prongay & Murray LLP, Los Angeles

Charles Linehan, 310-201-9150 or 888-773-9224

[email protected]

www.glancylaw.com

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Legal Professional Services

MEDIA:

Logo
Logo

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Jianpu Technology, Inc. (JT)

LOS ANGELES, March 26, 2021 (GLOBE NEWSWIRE) — Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming April 19, 2021 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Jianpu Technology, Inc. (“Jianpu” or the “Company”) (NYSE: JT) American Depositary Shares (“ADSs” or “shares”) between May 29, 2018 and February 16, 2021, inclusive (the “Class Period”).

If you suffered a loss on your Jianpu investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, you can submit your contact information at https://www.glancylaw.com/cases/jianpu-technology-inc/. You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.

On February 16, 2021, Jianpu announced the results of its review into “transactions carried out by the Credit Card Recommendation Business Unit” with third-party business entities. The Company concluded that previously reported revenue and associated expenses had been inflated due to “certain transactions [that] involved third-party agents (including both upstream agents and downstream suppliers) with undisclosed relationships and some transactions [that] lacked business substance.” Jianpu stated that it “anticipates the total amount of overstated revenue for the fiscal years 2018 and 2019 to be approximately, RMB 90 million and RMB 164 million, respectively, representing approximately 4.5% and 10.1% of the total revenue previously reported.”

On this news, the Company’s share price fell $0.60, or 13%, to close at $3.94 per share on February 16, 2021, on unusually heavy trading volume.

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that certain of the Company’s transactions carried out by the Credit Card Recommendation Business Unit involved undisclosed relationships or lacked business substance; (2) that, as a result, Jianpu’s revenue and costs and expenses for fiscal 2018 and 2019 were overstated; (3) that there were material weaknesses in Jianpu’s internal control over financial reporting; (4) that, as a result of the foregoing, the Company’s fiscal 2018 Form 20-F was reasonably likely to be restated; and (5) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Follow us for updates on LinkedIn, Twitter, or Facebook.

If you purchased or otherwise acquired Jianpu ADSs during the Class Period, you may move the Court no later than April 19, 2021 to request appointment as lead plaintiff in this putative class action lawsuit. To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to the pending class action lawsuit, please contact Charles Linehan, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles, California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to [email protected], or visit our website at www.glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Glancy Prongay & Murray LLP, Los Angeles
Charles Linehan, 310-201-9150 or 888-773-9224
[email protected]
www.glancylaw.com



DEADLINE ALERT for OTRK, ATNX, LDOS, RRC: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

BENSALEM, Pa., March 26, 2021 (GLOBE NEWSWIRE) — Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.

Investors suffering losses on their investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in these class actions at 888-638-4847 or by email to [email protected].

Ontrak, Inc. (NASDAQ: OTRK)
Class Period: November 5, 2020 – February 26, 2021
Lead Plaintiff Deadline: May 3, 2021 

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that Ontrak’s largest customer evaluated the Company on a provider basis, valuing Ontrak’s performance based on achieving the lowest cost per medical visit rather than clinical outcomes or medical cost savings; (2) that, as a result, Ontrak’s largest customer did not find the Company’s program to be effective and was reasonably likely to terminate its contract with Ontrak; (3) that, because this customer accounted for a significant portion of the Company’s revenue, the loss of the customer would have an outsized impact on Ontrak’s financial results; and (4) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Athenex, Inc. (NASDAQ: ATNX)
Class Period: August 7, 2019 – February 26, 2021
Lead Plaintiff Deadline: May 3, 2021

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) the data included in the Oral Paclitaxel plus Encequidar NDA presented a safety risk to patients in terms of an increase in neutropenia-related sequalae; (2) the uncertainty over the results of the primary endpoint of objective response rate (ORR) at week 19 conducted by BICR; (3) the BICR reconciliation and re-read process may have introduced unmeasured bias and influence on the BICR; (4) the Company’s Phase 3 study that was used to file the NDA was inadequate and not well-conducted in a patient population with metastatic breast cancer representative of the U.S. population, such that the FDA would recommended a new such clinical trial; (5) as a result, it was foreseeable that the FDA would not approve the Company’s NDA in its current form; and (6) as a result, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.

Leidos Holdings, Inc. (NYSE: LDOS)
Class Period: May 4, 2020 – February 23, 2021
Lead Plaintiff Deadline: May 3, 2021

Throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that the purported benefits of the Company’s acquisition of L3Harris’ Security Detection & Automation businesses were significantly overstated; (2) that Leidos’ products suffered from numerous product defects, including faulty explosive detection systems at airports, ports, and borders; (3) that, as a result of the foregoing, the Company’s financial results were significantly overstated; and (4) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Range Resources Corporation (NYSE: RRC)
Class Period: April 29, 2016 – February 10, 2021
Lead Plaintiff Deadline: May 3, 2021

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) Range Resources had improperly designated the status of its wells in Pennsylvania since at least 2013; (2) the foregoing conduct subjected the Company to a heightened risk of regulatory investigation and enforcement, as well as artificially decreased the Company’s periodically reported cost estimates to plug and abandon its wells; (3) the Company was the subject of a DEP investigation from sometime between September 2017 to January 2021 for improperly designating the status of its wells; (4) the DEP investigation foreseeably would and ultimately did lead to the Company incurring regulatory fines; and (5) as a result, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.

To be a member of these class actions, you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. If you wish to learn more about these class actions, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020, by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to [email protected], or visit our website at www.howardsmithlaw.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
888-638-4847
[email protected]
www.howardsmithlaw.com



More Central Texans can take advantage of expanded Affordable Care Act subsidies starting April 1

American Rescue Plan Act increases health insurance premium assistance for most current enrollees; Opens subsidy eligibility to those previously ineligible

Austin, Texas, March 26, 2021 (GLOBE NEWSWIRE) — Sendero Health Plans wants Central Texans to know that they may be eligible for significant help with their monthly premium for Affordable Care Act (ACA) Marketplace health insurance plans, which is now even true if someone did not previously qualify for income-based subsidies. 

The recently passed American Rescue Plan Act of 2021 (ARPA) creates opportunities for those earning more than four times the federal poverty level to receive help on ACA Marketplace health insurance plans for the first time. Additionally, the ARPA caps a household’s premium contribution on a Silver plan to 8.5 percent of their annual income, down from 9.8 percent in previous years, which means many current Bronze plan holders can move to lower deductible Silver plans for the same monthly cost. The newly expanded subsidies take effect April 1.  

“This enhanced subsidy plan can be a huge lift for Central Texans who may have difficulty affording health insurance,” said Wesley Durkalski, president and CEO of Sendero Health Plans, Central Texas’ only community-supported non-profit Marketplace health insurance provider. “Even if you didn’t qualify for help with your monthly payment in the past, you may be able to see significant assistance under the new ARPA provisions, or even have your premium fully-covered.” 

Starting April 1, those earning up to 150 percent of the federal poverty level will be able to get Silver plans for a zero-dollar premium and significantly reduced deductibles. In the past, households at all income levels were required to contribute toward a portion of the Silver plan, the middle-tier plan offered on the Marketplace and the most-popular one due to reduced out-of-pocket costs as compared with a Bronze plan. 

“The changes contained in the ARPA means that lower-income individuals who might have wanted to enroll in a lower- deductible and out-of-pocket cost Silver plan, but couldn’t afford the monthly premiums, may now qualify for a Silver plan at no or a low monthly cost,” Durkalski said. “It’s a huge win for the overall health of Central Texas. More people will have access to high-quality health care.”  

Enroll in March to have health insurance effective April 1

While the new premium subsidies begin April 1, Sendero is encouraging Central Texans to enroll now for health insurance in order for it to be effective for all of April. 

“We are urging our family, friends and neighbors to enroll in March and enjoy the peace-of-mind in knowing they will be protected should they experience surprise health care costs starting April 1,” said Durkalski. “While new ACA enrollees will not see the new subsidies that reduce monthly costs until April 1 for plans effective May 1, right now the government’s plan is that enrollees will have the opportunity to claim a tax credit for any higher April costs on their 2021 taxes.”  

Other benefits under the ARPA Marketplace guidelines 

Central Texans with household incomes up to 400 percent of the federal poverty level will see increased premium assistance. For example, according to the Kaiser Family Foundation, a 40-year-old with a household income at 200 percent of the federal poverty level would pay an average of just $510 a year for a Silver plan premium, versus $1,664 a year in past years. 

Those with incomes above 400 percent of the federal poverty level will be eligible for marketplace subsidies for the first time ever. Additionally, their premium contributions for a Silver plan will be capped at 8.5 percent of their household income. 

“We expect to see a big enrollment increase for those who are just above 400 percent of the federal poverty level. These are the households that also have struggled to afford health insurance and were forced to choose between paying high deductibles and out-of-pocket expenses for expensive insurance premiums or look for short-term or alternative health care solutions,” Durkalski said. 

The changes to the ACA Marketplace premium subsidies are not permanent at this time: They are effective only during the 2021 and 2022 calendar years. 

Those who already enrolled for a 2021 Marketplace plan during the 2020 Open Enrollment period can take advantage of these changes, too. Current enrollees need to go to  HealthCare.gov or to Sendero’s website for its members to request the higher subsidy and will also be able to change their plans during the current Enrollment period which runs through May 15, 2021.  Details for implementation of retroactive assistance are still being worked out, but subsidies for current enrollees are retroactive to January 2021.  

Sendero Health Plans offers guidance to those who wish to take advantage of the new ARPA expanded premium subsidies. Those with questions or who would like to enroll directly in a marketplace plan can visit Sendero’s website at www.SenderoHealth.com or by calling 1-844-800-4693. 

### 

 

Sendero Health Plans Inc., formed in 2011, is a community-supported nonprofit Health Maintenance Organization affiliated with the Travis County Health District, known as Central Health. Sendero is dedicated to improving the health of the community by providing affordable, quality healthcare coverage, especially for Travis County residents with low income. Sendero offers its IdealCare plans on the Federal Health Insurance Marketplace and is available in Travis, Williamson, Hays, Bastrop, Burnet, Fayette, Lee and Caldwell counties.



Bill Noble
Sendero Health Plans
512-296-4651
[email protected]

NOTICE OF ANNUAL GENERAL MEETING IN BIOTAGE AB (publ)

PR Newswire

UPPSALA, Sweden, March 26, 2021 /PRNewswire/ — The shareholders in Biotage AB (publ), Reg. No. 556539-3138, with its registered office in Uppsala kommun, Uppsala län, are hereby summoned to the Annual General Meeting, to be held on Wednesday, 28 April 2021.

In order to mitigate the spread of Covid-19, the Board of Directors has decided that the Annual General Meeting will be conducted by advance voting only, without physical presence of shareholders, proxies and third parties. Biotage welcomes all shareholders to exercise their voting rights at this Annual General Meeting through advance voting on the basis of temporary statutory rules, according to the procedure set out below. Information on the resolutions passed at the Annual General Meeting will be published on 28 April 2021, as soon as the result of the voting has been finally confirmed.

In the advance voting form, the shareholders may request that a resolution on one or several of the matters on the proposed agenda below should be deferred to a so-called continued general meeting, which cannot be conducted solely by way of advance voting. Such continued general meeting shall take place if the Annual General Meeting so resolves or if shareholders with at least one tenth of all shares in the company so request.

Notice, etc.

Shareholders who wish to participate in the Annual General Meeting must

a) be recorded as a shareholder in the share register maintained by Euroclear Sweden AB on Tuesday, 20 April 2021, and

b) notify the company of their intention to participate in the Annual General Meeting by casting their advance vote in accordance with the instructions under the heading “Advance voting” below, so that the advance voting form is received by Biotage no later than on Tuesday, 27 April 2021.

Advance voting

The shareholders may only exercise their voting rights at the general meeting by voting in advance, so-called postal voting in accordance with section 22 of the Act (2020:198) on temporary exceptions to facilitate the execution of general meetings in companies and other associations. A special form shall be used for advance voting. The form is available on Biotage’s website, www.biotage.com. The advance voting form is considered as the notification of participation.

The completed voting form must be received by the company no later than 27 April 2021. The form may be submitted by e-mail to [email protected] or by post to Biotage AB (publ), c/o Advokatfirman Vinge, Box 1703, SE-111 87 Stockholm, Sweden.

The shareholder may not provide special instructions or conditions in the voting form. If so, the vote (i.e. the advance vote in its entirety) is invalid. Further instructions and conditions are included in the form for advance voting.

If the shareholder votes in advance by proxy, a dated power of attorney shall be issued in writing for the proxy. If the power of attorney is issued by a legal entity, a certified copy of the registration certificate or similar for the legal entity shall be enclosed. A proxy form is available at www.biotage.com and is to be enclosed to the advance voting form.

Nominee registration

Shareholders whose shares are registered in the name of a nominee through a bank or a securities institution must register their shares in their own names to be entitled to participate in the general meeting. Such registration may be temporary (so-called voting rights registration) and is requested from the nominee in accordance with the nominee’s procedures and such time in advance as the nominee determines. Voting rights registration completed not later than the second banking day after 20 April 2021 are taken into account when preparing the register of shareholders r.

Right to request information

The shareholders are reminded of their right to request information according to chapter 7, section 32 of the Swedish Companies Act. A request for such information shall be made in writing to Biotage AB (publ), Biotage AB (publ), c/o Advokatfirman Vinge, Box 1703, SE-111 87 Stockholm, Sweden or by e-mail to [email protected], no later than on 18 April 2021. Information relating to such requests will be made available at Biotage AB (publ), Vimpelgatan 5, SE-753 18 Uppsala, Sweden, and on www.biotage.com, no later than on 23 April 2021. The information will also be sent, within the same period of time, to shareholders who so request and state their address.

Number of shares and votes

As of the date of this notice there are a total of 65,201,784 ordinary shares in the company that entitle to one vote per share at the Annual General Meeting. Further, the company holds 243,313 own class C shares, which entitle to one tenth of a vote per share and which cannot be represented at the Annual General Meeting. The class C shares do not entitle to dividends. Thus, there are a total of 65,445,097 shares and 65,226,115.3 votes in the company, of which 65,201,784 shares and votes can be represented at the Annual General Meeting.

Proposed Agenda

1. Election of the Chairman of the Annual General Meeting.

2. Election of two persons to approve the minutes

3. Preparation and approval of the voting list.

4. Approval of the agenda.

5. Determination whether the Annual General Meeting has been duly convened.

6. Presentation of the annual report and the auditor’s report, as well as the consolidated accounts and the auditor’s report on the consolidated accounts.

7. Resolutions on approval of the income statement and the balance sheet, and the consolidated income statement and the consolidated balance sheet.

8. Resolution on allocation of the company’s profit or loss pursuant to the approved balance sheet.

9. Resolution on discharge from liability for the board members and the CEO.

10. Resolution on the number of board members to be elected by the Annual General Meeting, and the number of auditors.

11. Resolution on the fees payable to the Board of Directors and the auditors.

12. Election of board members and Chairman of the Board of Directors.

13. Election of auditors.

14. Resolution on the nomination committee.

15. Presentation of the Board of Directors’ remuneration report for approval

16. Resolution on adoption of changes in the Articles of Association.

17. Resolution on adoption of long-term incentive plan (LTIP).

18. Resolution on authorization for the Board of Directors to issue shares.

 a) Main proposal

 b) Alternative proposal

Proposals of the nomination committee

Items 1 and 10 to 13 – Election of Chairman at the Annual General Meeting, resolution on the number of board members to be elected by the Annual General Meeting and the number of auditors, resolution on fees payable to the Board of Directors and auditors and election of board members and Chairman of the Board of Directors and election of auditors

The nomination committee of Biotage AB, consisting of Marianne Flink, Chairman (appointed by Swedbank Robur Fonder), Jonathan Schönbäck (appointed by ODIN Fonder), Christoffer Geijer (appointed by SEB Investment Management), and Torben Jörgensen (Chairman of the Board of Directors) proposes the following:

– Torben Jörgensen, or the person appointed by the nomination committee if he has an impediment to attend, shall be elected Chairman of the Annual General Meeting.

– Six board members (with no deputy board members) shall be elected and the number of auditors shall be one registered public accounting firm.

– A fixed fee to the Board of Directors (fees for 2020 in brackets), including fees for work in committees, of SEK 2,345,000 (1,880,000) shall be determined for the period up to and including the Annual General Meeting 2022 to be distributed as follows: The Chairman shall receive SEK 675,000 (500,000) and each of the other board members elected by the Annual General Meeting who are not employed by the company shall receive SEK 280,000 (225,000). Furthermore, a fee shall be paid to the members of the auditing committee of an aggregate of not more than SEK 160,000 (145,000), whereof the Chairman shall receive SEK 90,000 (75,000) and the other two members SEK 35,000 (35,000) each and a fee shall be paid to the members of the compensation committee of an aggregate of not more than SEK 110,000 (110,000), whereof the Chairman shall receive SEK 60,000 (60,000) and the other two members SEK 25,000 (25,000) each.

– Fees payable to the auditors for the period up to and including the Annual General Meeting 2022 shall, as before, be paid against approved account.

– Re-election for the period until the end of the Annual General Meeting to be held 2022 of the currently elected members of the Board of Directors, Torben Jörgensen, Peter Ehrenheim, Thomas Eklund, Karolina Lawitz, Åsa Hedin and Mark Bradley. Torben Jörgensen is proposed to be elected as Chairman of the Board of Directors.

– Election of the auditing firm Öhrlings PricewaterhouseCoopers AB (“PwC“), as the company’s auditor for the period until the end of the Annual General Meeting to be held 2022. Leonard Daun is proposed by PwC as auditor in charge if they are elected. The proposal is in accordance with the audit committee’s recommendation.

A presentation of all the individuals proposed by the nomination committee for election is available at

www.biotage.com

.

Item 14 – Resolution on the nomination committee

The nomination committee proposes that the Annual General Meeting resolves the following:

The company shall have a nomination committee consisting of four members. The members should be one representative of each of the three largest shareholders in the company with regard to the number of votes held who wish to appoint such representatives, together with the Chairman of the Board of Directors whom also shall convene the first meeting of the nomination committee. The nomination committee shall perform the duty of the nomination committee in accordance with the Swedish Corporate Governance Code. The nomination committee’s term of office shall extend until a new nomination committee is appointed.

The nomination committee shall be composed based on shareholder statistics from Euroclear Sweden AB as of the last banking day in August and other reliable shareholder information which has been provided to the company at such time. When determining who are the three largest shareholders with regard to the number of votes held, a group of shareholders shall be considered as one owner if they (i) have been organized as a group in the Euroclear-system or (ii) have made public and notified the company that they have made a written agreement to take – through the coordinated exercise of voting rights – a common long-term view on the management of the company. The nomination committee shall appoint one of the members, who is not the Chairman of the Board of Directors, as Chairman of the nomination committee. The Chairman of the nomination committee shall, if the nomination committee does not resolve otherwise, be the member that represents the largest shareholder with regard to the number of votes held. The names of the representatives and the names of the shareholders they represent shall be announced as soon as they have been appointed.

If, during the term of office of the nomination committee, one or more shareholders having appointed a representative to the nomination committee no longer is among the three largest shareholders with regard to the number of votes held, representatives appointed by these shareholders shall resign and the shareholder or shareholders who then are among the three largest shareholders with regard to the number of votes held, may appoint their representatives. In the event that a member leaves the nomination committee before its term of office is completed, the shareholder who appointed the member shall appoint a new member. If this shareholder is no longer one of the three largest shareholders with regard to the number of votes held, a new member is appointed according to the above procedure. Unless there are special circumstances, no changes shall be made in the composition of the nomination committee if there are only marginal changes in the number of votes held or if the change occurs later than three months before the Annual General Meeting. A shareholder that has become one of the three largest shareholders, with regard to the number of votes held, due to a more significant change in the number of votes held later than three months before the Annual General Meeting shall, however, be entitled to appoint a representative who shall be invited to participate in the committee’s work as a co-opted member. A shareholder who has appointed a representative as member of the nomination committee has the right to dismiss such member and appoint a new representative as member of the committee. Changes in the composition of the nomination committee shall be announced as soon as they have occurred.

Proposals of the Board of Directors

Item 2 – Election of two persons to approve the minutes

Marianne Flink, representing Swedbank Robur Fonder, and Christoffer Geijer, representing SEB Investment Management, or the person appointed by the Board of Directors if one or both of them have an impediment to attend, are proposed to be elected to approve the minutes together with the chairman. The task of approving the minutes also includes verifying the voting list and that the advance votes received are correctly stated in the minutes of the general meeting.

Item 8 – Resolution on the appropriation of earnings

The Board of Directors proposes a dividend of SEK 1.50 per share. Record date for dividend is proposed to be Friday, 30 April 2021. Payment of dividend is thus estimated to be effectuated by Euroclear Sweden AB on Wednesday, 5 May 2021.

Item 16 – Resolution on adoption of changes in the Articles of Association

The Board of Directors proposes a new 11 § of the Articles of Association, and, as a result thereof, the numbering of the subsequent articles is adjusted. The proposal to adopt a new 11 § is proposed to enable the Board of Directors to collect powers of attorneys in accordance with the procedure described in Chapter 7, Section 4 of the Swedish Companies Act and to authorise the Board of Directors to decide that the shareholders shall be entitled to exercise their voting rights by post prior to a general meeting.

11 § Collection of powers of attorneys and postal voting

The Board of Directors may collect powers of attorney in accordance with the procedure described in Chapter 7, Section 4, second paragraph 2 of the Swedish Companies Act (2005:551).

The board of directors has the right before a shareholders’ meeting to decide that shareholders shall be able to exercise their right to vote by post before the shareholders’ meeting.

Item 17 – Resolution on adoption of long-term incentive plan

The Board of Directors proposes that the Annual General Meeting resolves to adopt a long-term incentive programme based on performance-based share rights for employees in the Biotage group (“LTIP 2021“) in accordance with this item 17.

Proposal to adopt LTIP 2021 and hedging arrangements

The programme in brief

LTIP 2021 is proposed to include the CEO, senior executives and other key employees, meaning that a maximum of 18 individuals within the Biotage group will be able to participate. Participants will be given the opportunity to receive ordinary shares free of charge within the framework of LTIP 2021, so-called “Performance Shares“, in accordance with the conditions set out below.

Within the framework of LTIP 2021, the company will allot participants rights to Performance Shares which means that, subject to certain conditions being met, the right to receive a Performance Share free of charge (“Share Rights“).

Terms and conditions

A Share Right may be exercised provided that the participant, with certain exceptions, from the start date of the LTIP 2021 for each participant, up until and including the date three years thereafter (the “Vesting Period“), is still employed by the Biotage group. The last date for the start of the LTIP 2021 shall be the day before the Annual General Meeting of Biotage in 2022. In addition to the requirement for the participant’s continued employment according to the above, the final number of Performance Shares that each participant is entitled to receive shall also be conditional upon the following performance conditions:

 i. 50 per cent of the Performance Shares related to the total shareholder return (the return to shareholders through an increased share price and reinvestments of any dividends during the Vesting Period) on the company’s ordinary shares during the Vesting Period (“Performance Condition 1“).

 ii. 25 per cent of the Performance Shares related to an average adjusted EBIT-margin during the period from and including the financial year 2021 and up to and including the financial year 2023 (the “Measurement Period“) (“Performance Condition 2“),[1] and

 iii. 25 per cent of the Performance Share related to average organic sales growth over the Measurement Period (“Performance Condition 3“).

Participants will be entitled to 50 per cent of the Performance Shares under Performance Condition 1 if the total shareholder return amounts to or exceeds 64.3 per cent (corresponding to 18 per cent per year) during the Vesting Period. For allotment of Performance Shares under Performance Condition 1, the total shareholder return for the company’s ordinary share must exceed 26 per cent (corresponding to 8 per cent per year) during the Vesting Period. In between the percentages, allotment will be made linearly.

Participants will be entitled to 25 per cent of the Performance Shares under Performance Condition 2 if the average EBIT-margin amounts to or exceeds 20 per cent during the Measurement Period. For allotment of Performance Shares under Performance Condition 2, the average EBIT-margin must exceed 17 per cent during the Measurement Period. In between the percentages, allotment will be made linearly.

Finally, participants will be entitled to 25 per cent of the Performance Shares under Performance Condition 3 if the average organic sales growth amounts to or exceeds 11 per cent during the Measurement Period. For allotment of Performance Shares under Performance Condition 3, the average organic sales growth must exceed 7 per cent during the Measurement Period. In between percentages, allotment will be made linearly.

Share Rights

The Share Rights shall, in addition to what is set out above, be governed by the following terms and conditions:

· Share Rights are allotted free of charge no later than the day before the Annual General Meeting 2022.

· Share Rights vest during the Vesting Period.

· Share Rights may not be transferred or pledged.

· Each Share Right entitles the participant to receive one Performance Share free of charge after the end of the Vesting Period (with certain exceptions where the Vesting Period may be accelerated) if the participant, with certain exceptions, is still employed by the Biotage group by the end of the Vesting Period.

Preparation of the proposal, design and administration

The Board of Directors, or a special committee set up by the board, shall be responsible for preparing the detailed design and administration of the terms and conditions of LTIP 2021, in accordance with the presented terms and guidelines including provisions on recalculation in the event of an in-between bonus issue, share split, rights issue and/or similar measures. No recalculations will be made in relation to paid dividends. In connection with any recalculations, the Board of Directors shall be entitled to make adjustments to meet specific foreign regulations or market conditions. The Board of Directors may also make other adjustments if significant changes in the Biotage group or in its environment would result in a situation where the adopted terms and conditions of LTIP 2021 no longer serve their purpose or the rationale for the proposal. Adjustments may, amongst other things, be decided with respect to the terms and conditions for measuring the Performance Conditions, and the basis for such calculation, and the growth rate targets under LTIP 2021 due to potential effects from or related to Covid-19.

Allotment of Share Rights

The participants are divided into different categories and, in accordance with the above, the Share Rights under LTIP 2021 may be allotted to the following participants in the different categories:

Category

Maximumnumber ofpersons

Maximum number of ShareRights

Maximum number of ShareRights per person in the category

CEO

1

32,698

32,698

Senior executives

11

130,779

11,889

Key employees

6

32,694

5,449

Receiving Performance Shares under LTIP 2021 and hedging arrangements

The Board of Directors has considered different methods for transfer of ordinary shares under LTIP 2021 in order to implement the programme in a cost-effective and flexible manner. The Board of Directors has found the most cost-effective alternative to be, and thus proposes that the Annual General Meeting resolves (a) to authorise the Board of Directors to resolve on a directed rights issue of not more than 243,252 class C shares to the participating bank, of which not more than 47,081 class C shares may be issued to secure social contributions arising as a result of LTIP 2021 and (b) to authorise the Board of Directors to resolve on the repurchase of all issued class C shares in accordance with the below.

Following conversion of the class C shares to ordinary shares, the ordinary shares are intended to be both transferred to LTIP 2021 participants as well as sold in the market in order to cover the cash-flow related to social contribution costs associated with LTIP 2021. For this purpose, the Board of Directors proposes that the Annual General Meeting resolves (c) to transfer not more than 196,171 ordinary shares free of charge to participants in accordance with LTIP 2021 and that not more than 47,081 ordinary shares may be sold to cover social contribution costs arising as a result of LTIP 2021.

Scope and costs for LTIP 2021

LTIP 2021 will be reported in accordance with IFRS 2, which means that the Share Rights will be expensed as personnel costs over the Vesting Period. The costs for LTIP 2021 is estimated to amount to a maximum of approximately SEK 18.8 million, excluding social contributions, accounted in accordance with IFRS 2 based on the following assumptions: (i) that 196,171 Share Rights are allotted, (ii) that the share price, at the beginning of LTIP 2021, is SEK 139 per ordinary share, and (iii) that the performance conditions are fully met. Based on the same assumption as above, and subject to social contributions of approximately 24 per cent and a share price increase of 64.3 per cent from the start of LTIP 2021 until the participants are allotted shares, the costs for social contribution costs are estimated to amount to SEK 10.4 million. The total cost for LTIP 2021, including costs according to IFRS 2, is therefore estimated to a maximum of SEK 9.8 million per year.

Dilution and effects on key ratios

Upon maximum allotment of Share Rights 196,171 ordinary shares will be allotted to participants under LTIP 2021, and that 47,081 ordinary shares will be used to secure social contributions arising as a result of LTIP 2021 which would entail a dilution effect of approximately 0.37 per cent of the total number of ordinary shares in the company.

Given the above assumptions regarding scope and costs, and that LTIP 2021 was introduced in 2019 instead, it is estimated that the key figure earnings per share for full year 2020 would have decreased from SEK 2.69 to approximately SEK 2.57.

If also the LTIP 2020 is included in the calculation, the maximum dilution effect would amount to approximately 0.74 percent of the ordinary shares in the company, as of the date of this notice.

Authorisation for the Board of Directors to issue new class C shares

The Board of Directors proposes that the Annual General Meeting resolves to authorise the Board of Directors, during the period until the Annual General Meeting 2022 on one or more occasions, to increase the company’s share capital by not more than SEK 338,120.28 by the issue of not more than 243,252 class C shares, each with a quota value of SEK 1.39. With deviation from the shareholders’ pre-emption rights, the participating bank shall be entitled to subscribe for the new class C shares at a subscription price corresponding to the quota value of the shares. The purpose of the authorisation and the reason for the deviation from the shareholders’ pre-emption rights in connection with the issue of shares is to ensure delivery of shares to employees under the long-term incentive programme, as well as to secure potential social contributions arising as a result of LTIP 2021.

Authorisation for the Board of Directors to repurchase class C shares

The Board of Directors proposes that the Annual General Meeting resolves to authorise the Board of Directors, during the period until the Annual General Meeting 2022, on one or more occasions, to repurchase class C shares. The repurchase may only be effected through an offer directed to all holders of class C shares and shall comprise all outstanding class C shares. Repurchases shall be effected at a purchase price corresponding to the quota value of the share. Payment for the acquired class C shares shall be made in cash. The purpose of the proposed repurchase authorisation is to ensure delivery of Performance Shares under LTIP 2021 and to secure possible social contributions arising as a result of LTIP 2021.

Decision to transfer own ordinary shares

The Board of Directors proposes that the Annual General Meeting resolves that class C shares that the company acquires based on the authorisation to repurchase class C shares in accordance with the above, may, following the re-classification into ordinary shares, be transferred free of charge to participants of LTIP 2021 in accordance with the adopted terms and conditions in order to secure possible social contributions arising as a result of LTIP 2021.

The Board of Directors therefore proposes that the Annual General Meeting resolves that not more than 196,171 ordinary shares may be transferred to participants in accordance with the terms and conditions of LTIP 2021 and that not more than 47,081 ordinary shares shall be transferred on Nasdaq Stockholm, including through a financial intermediary, at a price within the registered price range at the relevant time, to cover any social contributions in accordance with the terms and conditions of LTIP 2021. The number of shares to be transferred is subject to re-calculation in the event of a bonus issue, split, rights issue and/or other similar events.

The background and rationale for the proposal

The purpose of LTIP 2021 is to create conditions for motivating and retaining competent employees within the Biotage group and to increase the coherence between the employees’, shareholders’ and the company’s objectives, as well as to increase the motivation to reach and exceed the company’s financial targets. LTIP 2021 has been designed so that the programme includes both current and future senior executives and other key employees.

By offering Share Rights that are based on both share price development and partly on strategic goals, the participants are premiered for increased shareholder value/value-creating measures. LTIP 2021 also rewards employees’ continued loyalty and thus the long-term value growth of the company. After these considerations, the Board of Directors considers that LTIP 2021 will have a positive effect on the future development of the Biotage group and will consequently be beneficial for both the company and its shareholders.

The preparation of the proposal

LTIP 2021 has been prepared by the company’s Board of Directors and its Remuneration Committee in consultation with external advisors. LTIP 2021 has been discussed by the Board of Directors at a meeting held in March 2021.

Item 18 – Resolution on authorization for the Board of Directors to issue shares

Item 18a – Main proposal

The Board of Directors proposes that the Annual General Meeting adopts a resolution to authorize the Board of Directors to, until the Annual General Meeting 2022, at one or several occasions and with or without deviation from the shareholders’ pre-emption rights, adopt resolutions to issue ordinary shares. The Board of Directors shall have the right to resolve that the shares shall be paid in cash or be paid in kind or otherwise be subject to conditions referred to in Chapter 2, Section 5, second paragraph 1-3 and 5 of the Swedish Companies Act or that the shares shall be subscribed for with a right of set-off. The shareholders shall retain their preferential rights if the Board of Directors resolves to issue new shares against cash contribution. The number of ordinary shares issued may not correspond to a dilution of more than 15 percent of the total number of ordinary shares outstanding at the Annual General Meeting’s resolution on the proposed authorization, after full exercise of the hereby proposed authorization.

Notwithstanding what is stated above regarding preferential rights for existing shareholders in case of an issue of shares against cash contribution, directed issues may be made in order to finance acquisitions of companies or parts of companies. In case of a directed cash issue of shares, such issue shall be made at market terms and conditions. Considering the above, the Board of Directors shall also be authorized to resolve on such other conditions that the Board of Directors finds necessary to carry out the issues. The reasons for the right to deviate from the shareholders preferential rights are to enable the company to, in a quick and effective way, finance acquisitions of companies or parts of companies.

The Board of Directors, or any person appointed by the Board of Directors, shall be authorized to make minor adjustments of the resolution adopted by the Annual General Meeting in order to fulfil the registration with the Swedish Companies Registration Office (Sw. Bolagsverket).

Item 18b -Alternative proposal

If the proposal in item 18a above does not get the required supportive votes from the Annual General Meeting to be passed, the Board of Directors proposes that it is given an authorization to issue new ordinary shares corresponding to a dilution of not more than 10 percent, on the same terms and conditions as stated above in item 18a.

Majority requirements

A decision according to the proposal pursuant to items 16 and 18 above are valid only when supported by shareholders holding not less than two-thirds (2/3) of both the votes cast and of the shares represented at the Annual General Meeting. A decision according to the proposal pursuant to item 17 above is valid only when supported by shareholders holding not less than nine-tenths (9/10) of both the votes cast and of the shares represented at the Annual General Meeting.

Processing of personal data

For information on how your personal data is processed, see the integrity policy that is available at Euroclear’s webpage www.euroclear.com/dam/ESw/Legal/Privacy-notice-bolagsstammor-engelska.pdf.

Documents

The accounting documents, the auditor’s report, the remuneration report and the complete proposal for the resolutions under items 16-17 above together with the auditor’s report in accordance with Chapter 8, Section 54 of the Swedish Companies Act and the Board of Directors’ report in accordance with Chapter 18, Section 4 of the Swedish Companies Act will be held available at the company at the address Vimpelgatan 5 in Uppsala, Sweden, no later than three weeks prior to the Annual General Meeting. In addition, the motivated statement from the nomination committee will be available at the company’s address stated above no later than four weeks prior to the Annual General Meeting. The above documents will also be sent to all shareholders that intend to attend the Annual General Meeting and all other shareholders upon request and will also be available on the company’s website www.biotage.com.

This is an in-house translation of the Swedish original version. In case of any discrepancies between the English language version and the Swedish language version, the Swedish language version shall prevail.

_____________________Uppsala in March 2021

Biotage AB (publ)

The Board of Directors

This information was submitted for publication, through the agency of the contact persons set out above, at 17.00 CET on March 26, 2021.

Contact persons:

Tomas Blomquist, CEO
Tel: 0705 23 01 63,
[email protected]
Biotage AB
Box 8
SE-751 03 Uppsala
www.biotage.com

About Biotage

Biotage is a Global Impact Tech Company committed to solving society’s problems. We offer workflow solutions and products to customers in drug discovery and development, analytical testing and water and environmental testing.

Biotage is contributing to sustainable science with the goal to make the world healthier, greener and cleaner – HumanKind Unlimited.

Our customers span a broad range of market segments including pharmaceutical, biotech, contract research and contract manufacturers as well as clinical, forensic and academic laboratories in addition to organizations focused on food safety, clean water and environmental sustainability.

Biotage is headquartered in Uppsala in Sweden and employs approx. 485 people worldwide. The Group had sales of 1,092 MSEK in 2020 and our products are sold in more than 70 countries. Biotage’s share (BIOT) is listed in the Mid Cap segment on the NASDAQ Stockholm.Website: www.biotage.com[1] The adjusted EBIT-margin is measured as an average over FY 2021, FY 2022 and FY 2023 before deduction of costs for long-term incentive programs. This is equivalent to the measurement of LTIP 2020 which was adopted at the Annual General Meeting of 4 June 2020. 

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/biotage/r/notice-of-annual-general-meeting-in-biotage-ab–publ-,c3315327

The following files are available for download:

Cision View original content:http://www.prnewswire.com/news-releases/notice-of-annual-general-meeting-in-biotage-ab-publ-301256840.html

SOURCE Biotage

IIROC Trading Halt – ZONE

Canada NewsWire

VANCOUVER, BC, March 26, 2021 /CNW/ – The following issues have been halted by IIROC:

Company: Zonetail Inc.

TSX-Venture Symbol: ZONE

All Issues: Yes

Reason: At the Request of the Company Pending News

Halt Time (ET): 12:01 PM

IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

SOURCE Investment Industry Regulatory Organization of Canada (IIROC) – Halts/Resumptions

Mercury Insurance Reduces Rates for Auto Insurance in Arizona

Mercury auto policyholders will see an average savings of $84

PR Newswire

LOS ANGELES, March 26, 2021 /PRNewswire/ — Mercury Insurance today announced that its auto insurance rates for Arizona drivers are being reduced by an average of 5 percent. The reduction immediately applies to new customers and policy renewals beginning March 26, and will save Mercury policyholders an average of $84 a year.

“For nearly 60 years, Mercury has been providing best-in-class auto protection and great rates,” said Tom Coyne, auto line lead at Mercury Insurance. “We’re voluntarily reducing rates to put nearly three quarters of a million dollars back in the pockets of our customers because great insurance at an affordable price should be available to everyone.”

Mercury’s rate reduction applies to all drivers who get Private Passenger Automobile liability, comprehensive or collision coverages. Mercury operates through a network of 371 independent insurance agents in Arizona. Drivers can also go to www.mercuryinsurance.com to get a quote.

“There are even more ways to save money with Mercury,” said Coyne. “The rate reduction can also be combined with other discounts like accident free, multi-policy and our Auto+Home discount that could save customers up to 30% percent more. The savings can add up to a lot of money.” 

Coyne offers these tips when shopping for auto insurance:

  • Talk to a local Mercury agent. Our agents can help uncover additional savings and tailor a coverage package customized to meet your needs.
  • Insurance can be complicated, so it’s important to get expert advice from a professional local independent Mercury agent. They know the local area and can really help you get the right coverage at the best possible price.
  • Shop around to see what’s out there. Your agent can help do this for you.
  • Remember, price is only part of the equation. Be sure to select a company with a solid financial background that will be there for you when you need to make a claim. Mercury has earned A ratings from A.M. Best and Fitch, two of the industry’s leading independent rating agencies. Reviews and customer testimonials are also an important to consider. Mercury is a four-time honoree on Insure.com’s “Best Auto Insurance Companies” list and has been awarded many other accolades.

Mercury also offers homeowners insurance and business automobile insurance in Arizona.

About Mercury Insurance

Mercury Insurance (MCY) is a multiple-line insurance organization predominantly offering personal automobile, homeowners and commercial insurance through a network of independent agents in Arizona, California, Florida, Georgia, Illinois, Nevada, New Jersey, New York, Oklahoma, Texas and Virginia. Since 1962, Mercury has specialized in offering quality insurance at affordable prices. For more information visit www.mercuryinsurance.com.

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/mercury-insurance-reduces-rates-for-auto-insurance-in-arizona-301255224.html

SOURCE Mercury Insurance

SRG MINING ANNOUNCES CLOSING OF FIRST TRANCHE UNDER THE SPROTT CONVERTIBLE FINANCING IN SUPPORT OF ITS NAL BID

Montreal Quebec, March 26, 2021 (GLOBE NEWSWIRE) — Montreal, Quebec March 26, 2021 – SRG Mining Inc. (TSXV: SRG) (“SRG” or the “Company”) announced today that further to its press release dated January 26, 2021 announcing the  private placement in the form of a convertible debt financing for USD$7.5M (approximately CAD$9.53M) (the “Financing”) with Sprott Private Resource Lending II (Collector), LP (“Sprott”), the parties have fully closed the first tranche on January 26, 2021 for USD$800,000 (the “First Tranche”).

While the parties advance the finalization of the definitive convertible credit agreement for the total Financing which is expected in the coming weeks, they intend to amend the maturity date for the First Tranche, which was set to April 2, 2021 to July 31, 2022, all subject to the approval of TSX Venture Exchange.

The Company had entered into the Financing in support of its bid for the North American Lithium Inc. (“NAL”) assets pursuant to the procedures of the Sale and Investor Solicitation Process relating to NAL.

About SRG Mining

SRG Mining is a Canadian-based mining company focused on developing the Lola graphite deposit located in the Republic of Guinea, West Africa. SRG is committed to operating in a socially, environmentally, and ethically responsible manner.

For additional information, please visit SRG’s website at www.srgmining.com.

Contact :

Benoit La Salle, FCPA FCA

Email: [email protected]

 

Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This press release contains “forward-looking information” within the meaning of Canadian securities legislation. All information contained herein that is not clearly historical in nature may constitute forward-looking information. Generally, such forward-looking information can be identified by the use of forward-looking terminology such as “firm”, “anticipated”, “potential”, “will”, “continue”, “demonstrate”, “deliver”, “believe”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would” or “might”. Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking information, including but not limited to: (i) volatile stock price; (ii) the general global markets and economic conditions; (iii) the possibility of write-downs and impairments; (iv) the risk associated with exploration, development and operations of mineral deposits and mine plans for the Company’s mining operations; (v) the risk associated with establishing title to mineral properties and assets including permitting, development, operations and production from the Company’s operations being consistent with expectations and projections; (vi) fluctuations in commodity prices, finding offtake takers and potential clients or enforcing such agreements against same and other risks and factors described or referred to in the section entitled “Risk Factors” in the MD&A of the Company and which is available at www.sedar.com, all of which should be reviewed in conjunction with the information found in this news release.

Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in the forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such forward-looking information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such forward-looking information. Such forward-looking information has been provided for the purpose of assisting investors in understanding the Company’s business, operations and exploration plans and may not be appropriate for other purposes. Accordingly, readers should not place undue reliance on forward-looking information. Forward-looking information is given as of the date of this press release, and the Company does not undertake to update such forward-looking information except in accordance with applicable securities laws.

 

 

 



Ugo Landry-Tolszczuk
SRG Mining
[email protected]

Fannie Mae Prices $715 Million Green Multifamily DUS REMIC (FNA 2021-M1G) Under Its GeMS Program

PR Newswire

WASHINGTON, March 26, 2021 /PRNewswire/ — Fannie Mae (OTCQB: FNMA) priced a $715 million Green Multifamily DUS® REMIC under its Fannie Mae Guaranteed Multifamily Structures (Fannie Mae GeMS™) program on March 23, 2021. FNA 2021-M1G marks the fourth Fannie Mae GeMS issuance of 2021.

In the second decade of its Multifamily Green Financing business, Fannie Mae remains committed to generating positive environmental and social impact through our two Multifamily Green product types: our Green Building Certification (GBC) program and Green Rewards, our energy- and water consumption-reduction program. Combined, we have issued more than $90 billion of Multifamily MBS backed by these financing products. Through the Fannie Mae GeMS program, we have re-securitized an additional $11.7 billion in REMICs backed by Green MBS. As part of our efforts to improve the investor experience and add transparency, Fannie Mae changed the naming convention of the Green GeMS issuance to include a ‘G’ in the shelf name, so investors can more easily identify the bonds in the secondary market.

“The 2021-M1G is our 16th GeMS issuance backed by Green MBS collateral, building off of our $13 billion in Green MBS issued in 2020,” said Dan Dresser, Senior Vice President, Multifamily Capital Markets & Pricing. “March has been a busy issuance month and we were pleased with the investor focus on the M1G. The deal offers the growing number of ESG-related accounts in the market the ability to invest in 10-year, call-protected DUS collateral originated through our market-leading green financing program.”

The FNA 2021-M1G joins the FNA 2021-M1S as the second GeMS of the year issued under Fannie Mae’s recently published Sustainable Bond Framework, which covers Fannie Mae’s issuance of sustainable, social, and green bonds and incorporates Fannie Mae’s Multifamily Green Bond Framework. The Fannie Mae Green MBS program has received a “light green” second party opinion (SPO) from CICERO. The Sustainable Bond Framework, Green Bond Framework, CICERO’s SPO, issuance tracking, and other resources can be found on Fannie Mae’s new Sustainable Bonds website, launched to provide investors a single site for Multifamily and Single-Family green and social bonds.

All classes of FNA 2021-M1G are guaranteed by Fannie Mae with respect to the full and timely payment of interest and principal. The structure details for the multi-tranche offering can be found in the table below:

 


Class


Original Face


Weighted Average
Life


Coupon (%)


Coupon
Type


Spread


Offered


Price


A1

$65,000,000

7.16

1.404

Fixed/AFC

S+6

99.99


A2

$650,362,729

9.60

1.561

WAC

S+20

97.41


X

$65,000.000

7.05

0.156

WAC IO

Not Offered

Not Offered


Total


$715,362,729

 



Group 1 Collateral


UPB:                                                                  

$715,362,729


Collateral:                                                           

40 Green Fannie Mae DUS MBS


Geographic Distribution:                                           

TX (25.2%), CA (19.7%), IL (14.3%)


Weighted Average Debt Service Coverage Ratio (DSCR):     

1.92x


Weighted Average Loan-to-Value (LTV):          

66.1%

 

For additional information, please refer to the Fannie Mae GeMS REMIC Term Sheet (FNA 2021-M1G) available on the Fannie Mae GeMS Archive page.

About Fannie Mae
Fannie Mae helps make the 30-year fixed-rate mortgage and affordable rental housing possible for millions of people in America. We partner with lenders to create housing opportunities for families across the country. We are driving positive changes in housing finance to make the home buying process easier, while reducing costs and risk. To learn more, visit:
fanniemae.com | Twitter | Facebook | LinkedIn | Instagram | YouTube | Blog

Fannie Mae Newsroom

https://www.fanniemae.com/newsroom

Photo of Fannie Mae

https://www.fanniemae.com/resources/img/about-fm/fm-building.tif

Fannie Mae Resource Center
1-800-2FANNIE

Certain statements in this release may be considered forward-looking statements within the meaning of federal securities laws. In addition, not all securities will have the characteristics discussed in this release. Before investing in any Fannie Mae issued security, you should read the prospectus and prospectus supplement pursuant to which such security is offered. You should also read our most current Annual Report on Form 10-K and our reports on Form 10-Q and Form 8-K filed with the U.S. Securities and Exchange Commission (“SEC”) available on the Investor Relations page of our Web site at www.fanniemae.com and on the SEC’s Web site at www.sec.gov.

Cision View original content:http://www.prnewswire.com/news-releases/fannie-mae-prices-715-million-green-multifamily-dus-remic-fna-2021-m1g-under-its-gems-program-301256838.html

SOURCE Fannie Mae

Jeep® Brand Creates Jeep 4xe Charging Network, Works With Electrify America to Provide EV Charging at Off-road Trailheads Throughout the United States

PR Newswire

MOAB, Utah, March 26, 2021 /PRNewswire/ —

  • The Jeep® brand is establishing the Jeep 4xe Charging Network, installing EV Level 2 charging stations at Jeep Badge of Honor off-road trailheads around the United States over the next 12 months
  • Trailhead chargers coincide with launch of 2021 Jeep Wrangler 4xe plug-in hybrid — the most technically advanced and eco-friendly Wrangler yet — and will support future electrified Jeep vehicles
  • Moab, Rubicon Trail and Big Bear — iconic Jeep vehicle trails — will get the first charging stations and be operational this spring
  • Jeep 4xe Charging Network is operated by Electrify America; Jeep 4xe owners will get free charging via a custom mobile app
  • With 21 miles of all-electric range, the Jeep Wrangler 4xe can conquer even the toughest trails with zero emissions

Unveiled today as part of this year’s Easter Jeep® Safari, the Jeep brand is taking electrified propulsion beyond the paved road with the innovative 2021 Jeep Wrangler 4xe plug-in hybrid. Partnering with Electrify America to create the Jeep 4xe Charging Network, Jeep-branded EV charging stations will be installed at or near the trailheads of Jeep Badge of Honor off-road trails over the next year, allowing owners to take full-advantage of their electrified Jeep SUV.

Jeep 4xe charging stations are scheduled to open this spring at three of the most popular off-road sites and iconic trails for the Jeep brand — Moab, Utah; the Rubicon Trail in Pollock Pines, California; and Big Bear, California.

Additional Jeep 4xe Charging Stations are scheduled to be operational around the country by the end of 2021. The charging stations will be located near Jeep Badge of Honor trails, an industry exclusive off-road rewards program to support enthusiasts looking to earn a Badge of Honor for their new Jeep Wrangler 4xe.

Jeep 4xe Charging Stations will be either directly connected to the power grid or use solar power to generate electricity.

“Electrification opens a new chapter in the Jeep brand story, and it brings an entirely new level of excitement and enjoyment to our enthusiastic owners,” said Christian Meunier, Jeep brand CEO — Stellantis. “Key to making Jeep brand the greenest SUV brand is assuring our owners can enjoy the benefits of electric propulsion wherever they go, including the most iconic off-road trails in the country.”

Creating the network of EV charging stations at off-road trails coincides with the launch of the 2021 Jeep Wrangler 4xe plug-in hybrid, the most capable, technically advanced and eco-friendly Wrangler ever built. With the Wrangler 4xe, Jeep enthusiasts can explore nature’s beauty with zero-emission propulsion that provides instant, trail-conquering torque.

Beyond the Rubicon Trail, Big Bear and Moab sites, other locations for Jeep 4xe Charging Network EV chargers will be announced in the future.

Jeep is working with leading public charging network Electrify America to establish the trailhead charging sites and install the charging equipment. Jeep 4xe owners will be able to login to unlock free charging via a custom mobile app by Electrify America, which also allows drivers to initiate and monitor their charging session.

“It is our goal to provide electric vehicle drivers with the freedom to get to where they want to go — whether it be on a highway or off-road — and we look forward to bringing Jeep enthusiasts along on the journey,” said Giovanni Palazzo, president and chief executive officer of Electrify America. “Through the customizable electric vehicle charging offerings of our Electrify Commercial B2B brand, we were able to work with Jeep to identify where their drivers will need charging access most, and make it a reality.”

The Jeep 4xe Charging Network trailhead chargers will deliver Level 2 (240-volt) charging. With Level 2 charging, the 17 kilowatt-hour battery pack in the Jeep Wrangler 4xe can be fully recharged in about two hours, delivering up to 21 miles of electric range. Recharge times will be shorter for Wrangler 4xe owners looking to just top off the battery pack before heading out on the trail.

Delivering up to 375 horsepower and 470 lb.-ft. of torque, the 2021 Jeep Wrangler 4xe lets the driver tailor the performance of the hybrid powertrain to best match planned activities, via the E Selec modes.

The E Selec mode options include eSave, which saves the Wrangler 4xe’s battery charge for later use by prioritizing propulsion from the 2.0-liter engine. Additionally, the driver can choose between battery saving and battery charging during eSave via the Hybrid Electric Pages in the vehicle’s Uconnect monitor.

The 2021 Jeep Wrangler 4xe launched in Sahara 4xe ($47,995 MSRP) and Rubicon 4xe ($51,695 MSRP) trim levels. Prices exclude the available $7,500 federal tax credit, any additional eligible state and local credits, and $1,495 destination charges.

Jeep Wave® Customer Care Program 
Jeep Wave is a premium owner loyalty program filled with benefits and exclusive perks created to give Jeep owners the utmost care and dedicated 24/7 support. The Jeep Wave customer service program is available to the entire 2021 model-year Jeep brand lineup.

Jeep Wave program highlights include:

  • Three years of worry-free maintenance at Jeep dealerships, including oil changes and tire rotations
  • 24/7 support via phone or online chat
  • Trip interruption and first-day loaner coverage
  • VIP access to select, exclusive Jeep brand events

Electrify America 
Electrify America LLC, the largest open DC fast charging network in the U.S., is investing $2 billion over 10 years in Zero Emission Vehicle (ZEV) infrastructure, education and access. The investment will enable millions of Americans to discover the benefits of electric driving and support the build-out of a nationwide network of workplace, community and highway chargers that are convenient and reliable. Electrify America expects to install or have under development approximately 800 total charging stations with about 3,500 DC fast chargers by December 2021. During this period, the company will be expanding to 29 metros and 45 states, including two cross-country routes, delivering on its commitment to support increased ZEV adoption with a network that is comprehensive, technologically advanced and customer friendly. Electrify America earned the “2020 EV Charging Infrastructure Best-in-Test” award from umlaut, an independent testing & validation company, as published in Charged Electric Vehicles Magazine noting the brand’s accessibility and seamless customer experience. Electrify America’s Electrify Home® offers home charging solutions for consumers with flexible installation options. Electrify Commercial® provides expert solutions for businesses looking to develop electric vehicle charging programs. For more information, visit www.electrifyamerica.com and media.electrifyamerica.com.

Jeep Brand 
Built on 80 years of legendary heritage, Jeep is the authentic SUV with capability, craftsmanship and versatility for people who seek extraordinary journeys. The Jeep brand delivers an open invitation to live life to the fullest by offering a full line of vehicles that continue to provide owners with a sense of security to handle any journey with confidence. Jeep Wave, a premium owner loyalty and customer care program that is available to the entire Jeep lineup, is filled with benefits and exclusive perks to deliver Jeep owners the utmost care and dedicated 24/7 support.

The Jeep vehicle lineup consists of the Cherokee, Compass, Gladiator, Grand Cherokee, Renegade and Wrangler. To meet consumer demand around the world, all Jeep models sold outside North America are available in both left- and right-hand drive configurations and with gasoline and diesel powertrain options. Jeep is part of the portfolio of brands offered by leading global automaker and mobility provider Stellantis. For more information regarding Stellantis (NYSE: STLA), please visit www.stellantis.com.

Follow Jeep and company news and video on:
Company blog: http://blog.stellantisnorthamerica.com 
Media website: http://media.stellantisnorthamerica.com
Jeep brand: www.jeep.com
Facebook: www.facebook.com/jeep 
Instagram: www.instagram.com/jeep 
Twitter: www.twitter.com/jeep
YouTube: www.youtube.com/thejeepchannel or https://www.youtube.com/StellantisNA 

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/jeep-brand-creates-jeep-4xe-charging-network-works-with-electrify-america-to-provide-ev-charging-at-off-road-trailheads-throughout-the-united-states-301256830.html

SOURCE Stellantis